Lam Thomas S. 4

What Happened
Thomas S. Lam, a director of Astrana Health, Inc. (ASTH), was granted 41,667 restricted stock units (RSUs) on April 6, 2026. The grant was reported at $0.00 per share (acquisition value $0). This was an equity award (not a market purchase or sale); the RSUs are a contingent right to receive shares if vesting conditions are met.

Key Details

• Transaction date: April 6, 2026; Form 4 filed April 8, 2026 (filed within two business days; appears timely).
• Transaction type/code: Award/Grant (A).
• Shares granted: 41,667 RSUs; price reported: $0.00; reported acquisition value: $0.
• Vesting for these RSUs (F2): eight equal semi-annual installments beginning October 6, 2026, subject to continued employment.
• Other restricted stock referenced (F3): 51,667 shares vesting in two equal annual installments beginning March 5, 2027, and 13,334 shares vesting in two equal annual installments beginning April 1, 2027. The filing also “includes” the 41,667 RSUs described above.
• Beneficial ownership note (F1): Some securities noted in the filing are held by Allied Physicians of California, a professional medical corporation of which Lam is an officer/director/stockholder; Lam disclaims beneficial ownership of those entity-held shares except to the extent of any pecuniary interest.
• Shares owned after transaction: total post-transaction holding is not specified in the provided filing excerpt.

Context
RSUs convert to actual shares only when they vest and are typically subject to continued employment; they do not involve immediate cash outlay by the recipient. Awards like this are routine executive/director compensation and do not, by themselves, indicate buying or selling sentiment.